search
Back to results

RF TKA Prehabilitation

Primary Purpose

Knee Osteoarthritis

Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Radiofrequency
Sponsored by
McGill University Health Centre/Research Institute of the McGill University Health Centre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Knee Osteoarthritis

Eligibility Criteria

40 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Chronic knee pain, with Dynamic VAS ≥ 5
  • Scheduled for elective total knee arthroplasty
  • Functional impairment due to pain because of knee osteoarthritis
  • Taking medications to control the pain.
  • Ability to perform the 6 MWT.

Exclusion Criteria:

  • ASA physical status > 3
  • Morbid obesity (BMI >40)
  • Revision of total knee arthroplasty
  • Mayor neuropsychiatric disease
  • Mayor cardiac, renal or hepatic failure
  • Anemia (hematocrit <30%)
  • Immunosuppression
  • Rheumatoid arthritis
  • Allergy to opioids, to local anesthetics or other medications used in the study,
  • Chronic regular use of large doses of opioids (>20mg equivalent of morphine/day) or sedatives
  • Unwillingness to have spinal anesthesia
  • History of recent drug abuse
  • Contraindication to receive regional anesthesia (e.g. coagulation defect)
  • Inability to walk before the surgery
  • Inability to perform physical tasks
  • Contraindications to physical exercise and training
  • Prior mayor knee surgery
  • Connective tissue diseases affecting the knee
  • Serious neurologic disorders
  • Injection with steroids or hyaluronic acids during the previous 3 months
  • Active sciatic pain
  • Anticoagulant medications

Sites / Locations

  • Montreal General HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Radiofrequency group

Control (Sham Radiofrequency) group

Arm Description

In this group patients will receive in a sterile fashion continuous radiofrequency for 4 minutes to the 3 genicular nerves in the operative knee as well as Pulsed Radiofrequency at 42 degrees celsius, for 4 minutes (60-70 volts) to the saphenous nerve and the nerve to the Vastus Medialis, at the level of the adductor canal. The procedure is done under local anesthesia on an ambulatory basis. After the radiofrequency, Ropivacaine 0.5% 5 ml is injected to each one of the nerves, along with 5 milligrams of Methylprednisolone to each nerve. Once the procedure is completed (takes about 20 minutes), patients will be observed in the preoperative program facility for 30 minutes and then discharged home.

In this group patients will receive injections of the local anesthetic and steroids in the same anatomical locations, without activating the radiofrequency generator.

Outcomes

Primary Outcome Measures

change of 15% of the total distance walked during a 6MWT
change of 15% or more in total distance in six minute walk test from baseline

Secondary Outcome Measures

Change in WOMAC score
Change in score of WOMAC questionnaire
Change in knee pain levels assessed by VAS (Dynamic/Static)
Change in amount of daily pain relief medication consumption
Change in total time of the time up and go (TUG) test

Full Information

First Posted
August 20, 2018
Last Updated
November 28, 2018
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
search

1. Study Identification

Unique Protocol Identification Number
NCT03758300
Brief Title
RF TKA Prehabilitation
Official Title
Radiofrequency Facilitates the Prehabilitation Process in Patients Undergoing Total Knee Arthroplasty: Effects on Preoperative and Postoperative Functional Capacity. A Double Blind Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Unknown status
Study Start Date
December 1, 2017 (Actual)
Primary Completion Date
December 31, 2018 (Anticipated)
Study Completion Date
December 31, 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The purpose of this study is to compare the effects of the radiofrequency applied to the sensory innervation of the knee, with respect to a control group (standard therapy), in a prehabilitation program aiming to improve the functional recovery of patients undergoing TKA. In the present study, the investigators hypothesize that participants treated with radiofrequency 4-6 weeks before the surgery, should be able to effectively accomplish the prehabilitation program and, therefore, have a faster recovery of their functional status in the post operative period , compared with the control group (That use the present state of the art approach)
Detailed Description
Postoperative functional capacity following TKA surgery has been strongly associated with preoperative functional status. Presence of pain, poor strength and flexibility, and limited ability to complete physiological tasks have been shown to be consistent predictors of poor recovery from knee surgery. The postoperative period is associated with 30-40% decrease in functional capacity, and efforts have been made to facilitate the recovery by implementing rehabilitative measures over the period of weeks and months. However, the postoperative period might not be the best time to engage patients in intensive physiotherapy as they are easily tired and in pain. Preparing patients for the stress of surgery, called also prehabilitation, is emerging as a mean to optimize pre-operative status and increase functional reserve thus, increasing surgical stress tolerance. Observational and randomized controlled studies in patients scheduled for colorectal, thoracic, and spinal surgeries have suggested that a 4-6 weeks of moderate preoperative physical activity can lead to significant postoperative improvements in cardiorespiratory reserve and functional capacity. However, preliminary trials on the effect of a 6-8 weeks prehabilitation program with structured exercises prior to knee arthroplasty have reported contrasting results, and one of the reasons might be the high levels of pain encountered by these patients while exercising, therefore making it difficult to engage them in achieving effective prehabilitation. It would therefore, make sense if efforts were directed towards relieving pain thus, facilitating broader fitness enhancement strategies and improving the surgical experience and the recovery process. Common pharmacological methods to relieve osteoarthritic pain while waiting for surgery, include acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDS and Cox-2 inhibitors) and occasionally opioids. Non-surgical interventions, such as intra-articular injection with steroids or hyaluronic acids, acupuncture and periosteal stimulation therapy, are often used as complementary therapies of limited benefit. The use of pulsed and Continuous radiofrequency (PRF and CRF) to the saphenous nerve and the genicular nerves branches of the knee, have been shown to decrease significantly pain scores in 44% of patients with chronic OA of the knee for up to one year after the treatment. Akbasa et al. using the Western Ontario and McMaster Osteoarthritis Index (WOMAC), reported significant reduction of pain at rest, movement and flexion of the knee and increase in patient's satisfaction 6 months after the PRF treatment. Our group has recently demonstrated the benefits of radiofrequency treatment in patients waiting for total knee replacement TKA 9. More so, the investigators recent results reported to the American Society of Regional Anesthesia and Pain, showed in a randomized controlled trial promising results in terms of faster recovery of patients undergoing TKA, when they received RF instead of the standard postoperative analgesia technique 10. The present study is, as mentioned above, related to an already approved and finished study in this institution: 15-209-MUHC "Functional outcome and postoperative analgesia following total knee arthroplasty: a prospective, randomized, double blind comparison between continuous adductor canal block and pulsed radiofrequency of saphenous and genicular nerves of the knee". In that study, our research group was investigating the effects of the Radiofrequency treatment preoperatively on the postoperative pain and functional recovery, in patients who did not participate in a prehabilitation program.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
48 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Radiofrequency group
Arm Type
Experimental
Arm Description
In this group patients will receive in a sterile fashion continuous radiofrequency for 4 minutes to the 3 genicular nerves in the operative knee as well as Pulsed Radiofrequency at 42 degrees celsius, for 4 minutes (60-70 volts) to the saphenous nerve and the nerve to the Vastus Medialis, at the level of the adductor canal. The procedure is done under local anesthesia on an ambulatory basis. After the radiofrequency, Ropivacaine 0.5% 5 ml is injected to each one of the nerves, along with 5 milligrams of Methylprednisolone to each nerve. Once the procedure is completed (takes about 20 minutes), patients will be observed in the preoperative program facility for 30 minutes and then discharged home.
Arm Title
Control (Sham Radiofrequency) group
Arm Type
Sham Comparator
Arm Description
In this group patients will receive injections of the local anesthetic and steroids in the same anatomical locations, without activating the radiofrequency generator.
Intervention Type
Other
Intervention Name(s)
Radiofrequency
Intervention Description
See previous page
Primary Outcome Measure Information:
Title
change of 15% of the total distance walked during a 6MWT
Description
change of 15% or more in total distance in six minute walk test from baseline
Time Frame
18 weeks
Secondary Outcome Measure Information:
Title
Change in WOMAC score
Description
Change in score of WOMAC questionnaire
Time Frame
Baseline and 18 weeks
Title
Change in knee pain levels assessed by VAS (Dynamic/Static)
Time Frame
Baseline and 18 weeks
Title
Change in amount of daily pain relief medication consumption
Time Frame
Baseline and 18 weeks
Title
Change in total time of the time up and go (TUG) test
Time Frame
Baseline and 18 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Chronic knee pain, with Dynamic VAS ≥ 5 Scheduled for elective total knee arthroplasty Functional impairment due to pain because of knee osteoarthritis Taking medications to control the pain. Ability to perform the 6 MWT. Exclusion Criteria: ASA physical status > 3 Morbid obesity (BMI >40) Revision of total knee arthroplasty Mayor neuropsychiatric disease Mayor cardiac, renal or hepatic failure Anemia (hematocrit <30%) Immunosuppression Rheumatoid arthritis Allergy to opioids, to local anesthetics or other medications used in the study, Chronic regular use of large doses of opioids (>20mg equivalent of morphine/day) or sedatives Unwillingness to have spinal anesthesia History of recent drug abuse Contraindication to receive regional anesthesia (e.g. coagulation defect) Inability to walk before the surgery Inability to perform physical tasks Contraindications to physical exercise and training Prior mayor knee surgery Connective tissue diseases affecting the knee Serious neurologic disorders Injection with steroids or hyaluronic acids during the previous 3 months Active sciatic pain Anticoagulant medications
Facility Information:
Facility Name
Montreal General Hospital
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H3A 1A1
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
JF Asenjo, MD
Phone
514) 934-1934
Ext
43261
Email
jfasenjog@yahoo.com
First Name & Middle Initial & Last Name & Degree
JF Asenjo, MD

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

RF TKA Prehabilitation

We'll reach out to this number within 24 hrs